Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
919
currently held
Exits tracked
338
hand-checked
Sectors covered
1
across the portfolio
Countries covered
35
from every market
1,150 companies matching · Page 2 of 23
Morphosys
Seedfonds Bayern
GermanySector
Biotech
InvestorBayern Kapital
Entry
1996
Hold
28yr
Exit
2024
PipeBio
byFounders II
DenmarkSector
Biotech
InvestorbyFounders
Entry
2021
Hold
3yr
Exit
2024
Q32 Bio
Abingworth Bioventures VII
USSector
Biotech
InvestorAbingworth
Entry
2020
Hold
4yr
Exit
2024
ReNeuron Group
Obotritia Capital KGaA
United KingdomSector
Biotech
InvestorObotritia Capital
Entry
–
Exit
2024
Reunion Neuroscience
Novo Holdings Venture Investments
Canada
Sector
Biotech
InvestorNovo Holdings
Entry
2022
Hold
2yr
Exit
2024
SensID GmbH
Venture Capital Fonds MV GmbH
GermanySector
Biotech
InvestorGENIUS Venture Capital
Entry
2018
Hold
6yr
Exit
2024
Polaris
Motion Equity Partners Fund
FranceSector
Biotech
InvestorMotion Equity Partners
Entry
2017
Hold
6yr
Owners
6
Mineralys Therapeutics
BioDiscovery 6
FranceSector
Biotech
InvestorAndera Partners
Entry
2022
Hold
4yr
Owners
2
PetMedix
CIC Fund II
UKSector
Biotech
InvestorCambridge Innovation Capital
Entry
2019
Hold
4yr
Owners
2
Exit
2023
Sense Biodetection
CIC Fund I
UKSector
Biotech
InvestorCambridge Innovation Capital
Entry
2016
Hold
7yr
Owners
2
Synthelis
CASRA Capital
FranceSector
Biotech
InvestorCrédit Agricole Alpes Développement
Entry
2013
Hold
10yr
Exit
2023
Emergence Therapeutics
Gruenderfonds Ruhr I
GermanySector
Biotech
InvestorGruenderfonds Ruhr
Entry
2019
Hold
4yr
Owners
3
Exit
2023
Carisma Therapeutics
Wellington Partners Life Sciences
United StatesSector
Biotech
InvestorWellington Partners
Entry
2018
Hold
5yr
Owners
2
Exit
2023
CinCor Pharma
General Atlantic Growth Equity Fund
United StatesSector
Biotech
InvestorGeneral Atlantic
Entry
2019
Hold
4yr
Owners
2
Exit
2023
Diatech
Funds advised by TA Associates
ItalySector
Biotech
InvestorTA Associates
Entry
2021
Hold
3yr
Owners
2
Mablink
Capital Santé 2
FranceSector
Biotech
InvestorTurenne Groupe
Entry
2021
Hold
2yr
Owners
2
Exit
2023
adivo
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2018
Hold
5yr
Exit
2023
BianoGMP GmbH
Thueringer Startup-Fonds (TSF)
GermanySector
Biotech
Investorbm-t Beteiligungsmanagement Thueringen
Entry
2018
Hold
5yr
Exit
2023
Calixar
Capital 2
FranceSector
Biotech
InvestorXAnge
Entry
2012
Hold
11yr
Exit
2023
Caraway Therapeutics
Dementia Discovery Fund
United StatesSector
Biotech
InvestorSV Health Managers
Entry
2017
Hold
6yr
Exit
2023
EryDel
Innogest Capital I
ItalySector
Biotech
InvestorOrigine SGR
Entry
2008
Hold
15yr
Exit
2023
Lexeo Therapeutics
Lundbeckfonden BioCapital
United StatesSector
Biotech
InvestorLundbeckfonden BioCapital
Entry
2021
Hold
2yr
Exit
2023
Oculis
Earlybird Health
SwitzerlandSector
Biotech
InvestorEarlybird Venture Capital
Entry
2020
Hold
3yr
Exit
2023
T3 Pharmaceuticals
Boehringer Ingelheim Venture Fund
SwitzerlandSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2019
Hold
4yr
Exit
2023
Zihpp
IP Group (Evergreen)
UKSector
Biotech
InvestorIP Group
Entry
2019
Hold
4yr
Exit
2023
c-LEcta
MFT Mittelstands-Fonds Thueringen (MFT)
GermanySector
Biotech
Investorbm-t Beteiligungsmanagement Thueringen
Entry
2006
Hold
16yr
Owners
3
Exit
2022
HTL Biotechnology
Montagu VI
FranceSector
Biotech
InvestorMontagu Private Equity
Entry
2018
Hold
5yr
Owners
2
Transcure
Ledger Cathay Fund
FranceSector
Biotech
InvestorCathay Capital
Entry
2014
Hold
8yr
Owners
2
DJS Antibodies
LifeArc Ventures
UKSector
Biotech
InvestorLifeArc
Entry
2016
Hold
6yr
Owners
2
Exit
2022
Algenex
Columbus Innvierte Life Science Fund I
SpainSector
Biotech
InvestorColumbus Venture Partners
Entry
2017
Hold
5yr
Exit
2022
Belyntic
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2019
Hold
3yr
Exit
2022
CEVEC Pharmaceuticals
NRW.Venture
GermanySector
Biotech
InvestorNRW.BANK
Entry
2009
Hold
13yr
Exit
2022
Ducentis BioTherapeutics
LifeArc Ventures
UKSector
Biotech
InvestorLifeArc
Entry
2019
Hold
3yr
Exit
2022
Lipofabrik
Re-Sources Capital
FranceSector
Biotech
InvestorRe-Sources Capital
Entry
2018
Hold
4yr
Exit
2022
MAIA Biotechnology
KIZOO Evergreen (Balance Sheet)
United StatesSector
Biotech
InvestorKIZOO Technology Capital
Entry
2019
Hold
3yr
Exit
2022
MiroBio
Oxford Science Enterprises Balance Sheet
UKSector
Biotech
InvestorOxford Science Enterprises
Entry
2019
Hold
3yr
Exit
2022
PearlRiver Bio
TVM Life Science Ventures
GermanySector
Biotech
InvestorTVM Capital Life Science
Entry
2020
Hold
2yr
Exit
2022
PepGen
Oxford Science Enterprises Balance Sheet
United StatesSector
Biotech
InvestorOxford Science Enterprises
Entry
2018
Hold
4yr
Exit
2022
Redpin Therapeutics
4BIO Ventures II
USSector
Biotech
Investor4Bio Partners
Entry
2020
Hold
2yr
Exit
2022
Renovacor
Innogest Capital II
United StatesSector
Biotech
InvestorOrigine SGR
Entry
2019
Hold
3yr
Exit
2022
ReViral
BioDiscovery 4
United KingdomSector
Biotech
InvestorAndera Partners
Entry
2015
Hold
7yr
Exit
2022
S-Biomedic
Oscar & Paul Venture Capital Fund I
BelgiumSector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2018
Hold
4yr
Exit
2022
Senti Biosciences
Leaps by Bayer
United StatesSector
Biotech
InvestorLeaps by Bayer
Entry
2021
Hold
1yr
Exit
2022
VAXIMM
Sunstone Life Science Ventures III
GermanySector
Biotech
InvestorSunstone Life Science Ventures
Entry
2011
Hold
11yr
Exit
2022
Versantis
Invivo Ventures
SwitzerlandSector
Biotech
InvestorInvivo Partners
Entry
2017
Hold
5yr
Exit
2022
Sophia Genetics
Eurazeo Growth Fund III
SwitzerlandSector
Biotech
InvestorEurazeo
Entry
2014
Hold
7yr
Owners
4
IO Biotech
Kurma Biofund III
FranceSector
Biotech
InvestorEurazeo
Entry
2015
Hold
7yr
Owners
3
Modus Therapeutics
HealthCap VII
SwedenSector
Biotech
InvestorHealthCap
Entry
2011
Hold
15yr
Owners
3
Aldevron
TA Associates Portfolio
USASector
Biotech
InvestorTA Associates
Entry
2019
Hold
2yr
Owners
2
BioNTech
Athos Evergreen Life Sciences
GermanySector
Biotech
InvestorAthos
Entry
2008
Hold
18yr
Owners
2